Unravelled potato genome paves the way for new varieties
Paving the way
Now that the sequence of the building blocks of the potato genome is known, this paves the way for researchers and breeders to raise the yield of the crop, improve its quality and nutritional value as well as make the plant more resistant to disease. Crossing disease-resistant characteristics usually takes up to fifteen years and this process can now be considerably reduced.
The potato is the most important food crop that is not a grain (wheat, rice). According to the World Food and Agriculture Organisation (FAO), global production is around 330 million tons a year. Potatoes are an important source of starch, protein, antioxidants and vitamins, for both man and animal, while starch can be used for green materials, including paper and textiles.
The potato acreage has changed very little in recent decades. While the cultivation area in Eastern Europe shrank, it tripled in developing countries. For these countries, the potato has become an attractive crop, because potato plants use water and nutrients efficiently and potato growers increasingly have access to good seeds.
These seeds often come from Dutch growers. There are over 4000 cultivated potato varieties, often known by strange names like Desiree, Agria, Maris Piper and Bintje.
The Potato Genome Sequencing Consortium (PGSC) consists of 29 research groups from fourteen countries including China, Russia, India, Chile, Italy, New Zealand and Argentina. The Wageningen UR Plant Breeding expertise group was founded in 2005 and is a partnership between the Laboratory for Plant Breeding at Wageningen University and the Biodiversity and Breeding Business Unit of Plant Research International, both parts of Wageningen UR.
Original publication
"Genome sequence and analysis of the tuber crop potato."; Nature 2011.
Original publication
"Genome sequence and analysis of the tuber crop potato."; Nature 2011.
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.